HENLIUS 02696Hong Kong Stock Exchange

50.7500.20%( +0.100 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
HENLIUS (02696) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2019-09-25
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100003N76

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)7.82B23/112
Net Profit (Last FY)969.84M21/125
ROE (Last FY)20.88%9/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Jun Zhu Executive Director
Wenjie Zhang Non-Executive Director
Qiyu Chen Non-Executive Director
Yuqing Chen Non-Executive Director
Xiaohui Guan Non-Executive Director
Yi Liu Non-Executive Director
Xingli Wang Non-Executive Director
Tak Young So Independent Non-Executive Director
Lik Yuen Chan Independent Non-Executive Director
Ruilin Song Independent Non-Executive Director
Yihao Zhang Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-08-29.

About this page

This page shows HENLIUS (02696) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.